Cloud Peak Energy emerges from chapter 11
Davis Polk advised an ad hoc group of secured noteholders and the DIP facility agent in connection with the restructuring of Cloud Peak Energy Inc. and certain of its affiliates and with…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Advises Reliance Industries Limited in Connection with Its Agreement to Establish a Joint Venture with BP plc
Davis Polk is advising Reliance Industries Limited in connection with its agreement to establish a joint venture to be held 51% by RIL and 49% by an affiliate of BP plc. The joint venture…
JB Financial Group acquisition of Morgan Stanley Gateway Securities
Davis Polk is advising JB Financial Group Co., Ltd. on its acquisition of Morgan Stanley Gateway Securities J.S.C. (“MSGS”) from Morgan Stanley (Singapore) Holdings Pte. Ltd., Thanh Ba…
Medallion Bank Initial Public Offering of Preferred Shares
Davis Polk advised the underwriters in connection with Medallion Bank’s initial public offering of 1,840,000 shares of Series F Preferred Shares, with an aggregate liquidation amount of $46…
New Jersey Resources Corporation Common Stock Offering and Forward Sale Agreements
Davis Polk advised the forward purchasers and the forward sellers in connection with the execution of forward sale agreements relating to an aggregate of 1,212,120 shares of New Jersey…
China South City Holdings Limited $150 Million High-Yield Notes Offering
Davis Polk advised the initial purchasers in connection with a $150 million Regulation S only offering by China South City Holdings Limited of its 11.5% senior notes due 2022.
CSC is a…
Davis Polk Advises Charles River on Its Acquisition of HemaCare
Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $380 million acquisition of HemaCare Corporation. The proposed purchase price equates to $25.40…
Davis Polk Advises Notre Dame Intermédica on Its R$5.0 Billion Equity Offering
Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame Intermédica and Bain Capital, a shareholder of Notre Dame Intermédica, of…
Forty Seven, Inc. $195.6 Million Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $195.6 million public offering of common stock of Forty Seven, …
Roche obtains approval for $4.3 billion acquisition of Spark Therapeutics
Davis Polk advised Roche on its approximately $4.3 billion acquisition of Spark Therapeutics, Inc., including coordinating all international regulatory filings. The acquisition was…